Mexico Pharmaceuticals Report - Q3 2025
Збережено в:
| Опубліковано в:: | Fitch Solutions Country Industry Reports (Third Quarter 2025), p. 1 |
|---|---|
| Опубліковано: |
Fitch Solutions Group Limited
|
| Предмети: | |
| Онлайн доступ: | Citation/Abstract Full Text - PDF |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
| Короткий огляд: | Despite facing challenges in drug procurement and patent enforcement, Mexico's pharmaceutical industry is poised for sustained growth, fuelled by an increasing demand for advanced treatments for chronic diseases. As the second largest pharmaceutical market in Latin America, Mexico offers significant opportunities for companies developing innovative medications. Nonetheless, relatively low per capita spending on pharmaceuticals could limit the widespread adoption of patented drugs, potentially boosting the market share of generics. Government initiatives aimed at enhancing local drug manufacturing are expected to foster more international partnerships, particularly in the area of technological exchange. |
|---|---|
| ISSN: | 2976-4750 |
| Джерело: | ABI/INFORM Trade & Industry |